Brief: Milestone Pharmaceuticals Announces Pricing Of $52.5 Million Public Offering
11/07/2025 15:29
July 11 (Reuters) - Milestone Pharmaceuticals Inc MIST.O: MILESTONE PHARMACEUTICALS ANNOUNCES PRICING OF $52.5 MILLION PUBLIC OFFERING OF COMMON SHARES, PRE-FUNDED WARRANTS, SERIES A COMMON WARRANTS AND SERIES B COMMON WARRANTS Source text: ID:nGNXb6SM0C Further company coverage: MIST.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Milestone Pharmaceuticals
See all newsBrief: Milestone Pharmaceuticals Announces First European Study Participant Enrolled In Revera-301 Phase 3 Clinical Trial
Brief: Milestone Pharmaceuticals Says NMPA Approval Triggers $2 Mln Milestone Payment To The Co
Milestone Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Canada's Milestone Pharma misses Q2 product revenue expectations
Milestone Pharmaceuticals Inc expected to post a loss of 19 cents a share - Earnings Preview